Jade Biosciences, Inc. · NASDAQ:JBIO
Janus Henderson Group PLC reported a 6.20% stake in Jade Biosciences, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Janus Henderson Group PLC reported a 6.20% stake in Jade Biosciences, Inc., 3,063,457 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 3,063,457
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.20% | 3,063,457 |
Source
Related
- Jade Biosciences, Inc.
- Janus Henderson Group PLC
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026